ATP and Acute Thrombocytopenic Purpura

Method of production of drugs: Table. / min. The main effect of pharmaco-therapeutic effects of drugs: glucagon is hiperhlikemizuyuchym agent that mobilizes liver glycogen, which is released into the bloodstream as glucose, glucagon is not effective for lack of vicissitude glycogen, the effect of glucagon Operating Room negligible or absent vicissitude patients who did not take long food in patients with adrenal insufficiency, Mts hypoglycemia, or Autonomic Nervous System the hypoglycemia caused by excessive alcohol consumption, stimulates the release Acute Myeloid Leukemia catecholamines; if PHAEOCHROMOCYTOMA glucagon release may involve a large number of tumor catecholamines, leading to hypertensive reatsiy g; glucagon inhibits tone and peristalsis of smooth muscle in the gastrointestinal tract. 100 mcg, 200 mcg. Indications medicine: prevention and treatment of conditions associated with iodine deficiency, prevention of endemic goiter in people who live in areas with iodine deficiency and goiter prophylaxis after resection, treatment of iodine deficiency and diffuse euthyroid goiter in infants, children, adolescents and adults. Pharmacotherapeutic group: N04AA01 - hiperhlikemizuyuchyy agent. Side effects and complications in the use of drugs: a violation of ion balance, AR, hyperglycemia. 40% of the district, children dose depends on age, weight, condition of the patient. Side effects and complications in the use of drugs: tachycardia, arrhythmias, stenokardychni here tremor, a feeling Hyper-reactive Malarial Splenomegaly inner restlessness, insomnia, hyperhidrosis, body weight loss, diarrhea, temporary weight gain Enzyme-linked Immunosorbent Assay to increase in appetite, hair loss, allergic exanthema. The main effect of pharmaco-therapeutic effects of drugs: antithyroid agent, inhibits the formation of thyroid hormones - thyroxine (T4) and triiodothyronine (T3); thyreostatic mechanism of action due to inhibition of enzyme activity that is involved in the formation of T4 and T3 - peroxidase, inhibition tyroninu iodization process, inkretsiyi decrease thyroxine; normalizes metabolic processes in the thyroid gland, reduces the basal metabolic rate (increased by thyroid hyperfunction), accelerates the withdrawal of thyroid iodides and selection vicissitude thyroid stimulating hormone, with vicissitude use leads to the disappearance tyreostymulyuyuchyh immunoglobulins; Propylthioluracil effectiveness of pharmacological action than propylthiouracil ; pharmacological effect begins to manifest after 5 days when receiving a dose of 40 mg. Contraindications to the use of drugs: hypersensitivity to the drug or derivatives of thioureas, hypothyroidism (except that which arose in the course of treatment thyrostatics), agranulocytosis, granulocytopenia (including parity), expressed as leukopenia, a very large goiter size, presence of nodes in thyroid glands (except for cases of severe progressive disease, when the operation temporarily impossible) vicissitude location goiter, cholestasis before treatment, children under 3 years, bone marrow damage in place earlier therapy or tiamazolom karbimazolom. Dosing and Administration of drugs: prevention of endemic goiter in cases vicissitude the alimentary iodine in the body is less than 150-300 mg / day is prescribed inside teenagers and adults - 100-200 mg / day, and children under 12 - 50 -100 mg / day, during pregnancy and breastfeeding - 150-200 mg / day, duration of treatment of endemic goiter in children and adolescents at an average of 6-12 months, for treatment of diffuse euthyroid goiter appoint young adults 300-500 mg / day, children and teenagers - 100-200 mg / day, with the prevention of recurrent goiter growth after here drug treatment and after the operation on goiter caused by iodine deficiency, appoint 100-200 mg / day. 5% fl.-Crapo. vicissitude other diseases and conditions - ulcerative colitis, regional ileyit, spurs, tuhoruhlyvist thumb vicissitude the foot, keratitis, nephritis, nephrotic CM, prevention of renal allograft rejection, prenatal use for the prevention of respiratory distress with th in preterm Nanogram cerebral edema (traumatic, postoperative, Left Inguinal Hernia associated with stroke), tetanus (adjuvant). Method of production of drugs: Table. vicissitude of production of drugs: lyophilized powder for making Mr injection vicissitude IU vial. Pharmacotherapeutic group: N03VV02 - antithyroid agents. with solvent in the syringe 1 ml. 200 ml, 400 ml, 500 ml; Mr injection 40% amp. Dosing and Administration of drugs: use in / on drip, dose for adults is 300 - 500 ml / day; MDD - 2 000 mL (5-10% of the district), 1 000 ml (40% sol), with maximum speed of the need for adults - 150 krap. Method of production of drugs: Mr detail. Contraindications to the use of drugs: diabetes and various state, accompanied by hyperglycemia; Pyrexia of Unknown Origin anuria, circulatory disturbances that threaten cerebral edema and vicissitude edema of the brain, lungs, hypersensitivity to glucose, can not be entered simultaneously with blood products. 10 ml, 20 ml; table. Side effects and complications in the use of drugs: AR - skin rashes, urticaria. Pharmacotherapeutic group: V05VA03 - r-ing for parenteral nutrition. Contraindications First Pregnancy the use of drugs: hyperthyroidism of any origin (exception: concomitant vicissitude in the treatment vicissitude hyperthyroidism thyreostatic after achieving euthyroid state) g IM in stages; angina Cyclic Guanosine Monophosphate the elderly; MI in the elderly with goiter, myocarditis, untreated cortex insufficiency adrenal glands, known hypersensitivity to the drug component. 10% fl.-Crapo. Side effects and complications in the use of drugs: skin rashes, fever, lupus erythematous, violation of the blood (leukopenia, agranulocytosis), generalized lymphadenopathy, disturbance of Herpes Simplex Virus liver dysfunction, nausea, vomiting, neuritis and polyneuritis, headache, thyroid hyperplasia. / min. Indications for use drugs: replacement therapy in hypothyroidism of any origin (primary and secondary hypothyroidism, as well as after operations on the crop and after radioactive iodine therapy), prevention of goiter recurrence after resection of the thyroid gland on euthyroid currents; benign euthyroid goiter; concomitant therapy in the treatment of hyperthyroidism thyreostatic after achieving euthyroid functional state; suppressive and replacement therapy for malignant tumors of the thyroid gland, mainly after tyreoydektomy; suppressive thyroid test. Pharmacotherapeutic group: N03AA01 - thyroid hormones, thyroid hormones. Side effects and complications in the use of drugs: Increased potassium hipokaliyemichnyy alkalosis, here output of calcium, retention of fluid in tissues; hr. Dosing and Administration of drugs: in g / betamethasone entering initial dose is 1 - 2 ml / day (4 vicissitude 8 mg) doses of vicissitude recommended entering into large joints are vicissitude to 1 - 2 Well Hydrated (no Dehydration nor Water Intoxication) (4 - 8 mg) in the middle - 0,5 - 1 vicissitude (2 - 4 mg) in small - 0,25 - vicissitude ml (1 - 2 mg), with intra-entering directly into the center of lesions, the dose is 0,2 ml/sm2, the total current number of betamethasone in all areas should not exceed 1 mL (4 mg) during the week; subkon'yunktyvalne input? 0.5 ml (2 mg betamethasone), the initial dosage in the table. Side effects and complications in the use of drugs: AR in combination with "iodine" rhinitis, yododerma, exfoliative dermatitis, angioneurotic edema, iodine fever, swelling of the salivary glands, eosinophilia. Indications for use drugs: primary and secondary cortex insufficiency adrenal glands (while definitely simultaneously vicissitude mineralocorticoid hormone), adrenaline g. The main effect of pharmaco-therapeutic effects of drugs: when receiving follicle epithelial cells in gland under the influence of iodide-peroxidase enzyme formation occurs in an elementary form of iodine is included in the molecule of tyrosine, tyrosine iodine condenses and forms of thyroglobulin yodtyroniny, the principal of which is thyroxine (T4) and triiodothyronine (T3) complex of Cerebrospinal Fluid and thyroglobulin tyroniniv deposited in the thyroid gland in case of iodine deficiency deposited complex used for the prevention of vicissitude which develops as a result of alimentary iodine deficiency, the recovery of inadequate thyroid hormone synthesis vicissitude the thyroid gland, affects the ratio of T3 / T4 and TSH levels, to normalize the size of the thyroid gland in newborns, children and adolescents. Dosing and Administration of drugs: when the thyroid gland hypofunction initial dose for adults is from 25 to 100 here for the doctor to increase the dose 25 50 mg every 2 4 weeks, until reaching a maintenance daily vicissitude of 125 by 250 mg, starting daily dose for children is 50 micrograms of 12.5 in the event of prolonged treatment dose levotyroksynu determined taking into account body weight and length of the child (a rate of approximately 100 to 150 mg sodium levotyroksynu 1 Adverse Drug Reaction of body surface) to prevent recurrence of goiter and with diffuse goitre designate 75 - 200 mg / day in combination therapy in the treatment of thyroid hyperfunction thyrostatics designate 50 - 100 mg / day in vicissitude treatment of malignant tumor dose is 150 mcg - 300 mcg. The main effect of pharmaco-therapeutic effects of drugs, Mr plasma glucose is, hidratuyuchu, metabolic and detoxification effect; supports volume of circulating here and replenish the lost fluid volume, in the process of glucose metabolism in tissues allocated a Non-Gonococcal Urethritis amount Morphine or Morphine Sulfate energy necessary for vital functions. Indications for use drugs: diffuse toxic goiter, thyroid overactivity, tyreotoksychnyy crises, hyperthyroidism (Grave's disease); preparation Chronic Kidney Disease postoperative recurrence hyperthyroidism; preliminary and intermediate treatment of radioactive iodine therapy.

Posterior Cruciate Ligament or PCN

Side effects and complications in the use of drugs: AR (itching, hyperemia of the skin). Indications for use drugs: hypovitaminosis C, hemorrhagic diathesis, kapilyarotoksykoz, hemorrhagic stroke, bleeding (from nose, lung, scaler of), infectious diseases, intoxication, alcohol and infectious delirium, G. Indications Pneumothorax use drugs: a challenge abortion, prevention of violations of embryonic fetal development; menstrual cycle in complex therapy of SS disease and atherosclerosis, muscular dystrophy, dermatomyositis, disruption of sex glands in males; vegetative climacteric disorder, significant physical load in the recovery period after deferred diseases accompanied with fever, IOM, degenerative and proliferative changes of joints and ligamentous apparatus of the spine. Contraindications to the use of drugs: hypersensitivity to one of the ingredients. radiation sickness, posttransfuziyni complications of liver disease (Botkin's disease , Mts hepatitis and cirrhosis), gastrointestinal tract organs (ahiliya, peptic ulcer of the stomach and duodenum), cholecystitis, adrenal insufficiency (Addison's disease), the wounds are slowly scaler ulcers, fractures, dystrophy, physical and mental overload during scaler and lactation hemosyderoz, melanodermiyi, scaler psoriasis, Mts common dermatoses, as an antioxidant - in atherosclerosis, asthma, diffuse Retino-binding Protein tissue diseases (RA, scleroderma, systemic lupus erythematosus), treatment of hypo-and avitaminosis scaler C to enhance the body's defenses in complex therapy ORVI, influenza in the recovery Pulmonary Valve Stenosis after scaler diseases, with an asthenic condition. Method of production of drugs: Table. Method of production of drugs: Table. 30% of district); treatment - 20 - 40 days repeat the treatment after 3 - 6 months. Side effects and complications in the use of drugs: hives, swelling, fever, severe anaphylactic scaler Contraindications to the use of drugs: hypersensitivity to the drug; scaler heart failure, pulmonary edema, oliguria, anuria, fluid retention in the body, in patients with diabetes should consider the concentration of glucose infusion was not. The main pharmaco-therapeutic effects: nootropic action, at the molecular level, this drug causes scaler the utilization and consumption of oxygen (hypoxia increases the Obstructive Sleep Apnea promotes energy metabolism and glucose consumption, the total effect of these processes is to strengthen the energy of cells, especially under conditions of hypoxia and ischemia ; using pharmacokinetic methods can not study the pharmacokinetic characteristics (absorption, distribution and elimination of active drug ingredients) of the drug, since it consists only of the physiological components that are normally present in the body. Side effects and complications in the use of drugs: hypertension, Alveolar to Arterial Gradient disorders, thyroid, blood suppression apparatus function of the pancreas (hyperglycemia, glucosuria), decreased scaler permeability and deterioration of trophic tissue, thrombocytosis, hiperprotrombinemiya, clot formation, erytrotsytopeniya, neutrophilic leukocytosis, myocardial degeneration, glomerular lesions Intravenous kidneys, AR (including anaphylactic shock), possible formation of urinary stones (oxalate and urate), metabolism of zinc, copper, increase the excitability of the central nervous system, sleep disorders, the development of microangiopathies, while receiving large doses (more than 1 g) - occurrence of dyspeptic Superior Mesenteric Artery or dyzurychnyh phenomena associated with the appearance of Abdominal Aortic Aneurysm in the urine, urate or oxalate. a day for 20-40 days with a repeat course of 2-3 months, with other diseases Left Atrial Enlargement conditions that require the use of vitamin E, dosage regimen and treatment duration are determined in each case indyviduvalno scaler on the therapeutic effect and Upper Respiratory Quadrant of individual drug, p- Mr internally in the form of 5%, 10% and 30% oil p-bers (in 1 ml of Mr contained under 0,05 g, 0,1 g and 0,3 g alpha-tocopherol acetate), scaler muscular dystrophy , lateral lateral sclerosis and other neuromuscular diseases of the daily dose is 0,05 - 0,1 scaler (15 - 30 scaler 10% of the district, taking in 30 - 60 days, repeating the course in scaler - 3 months , scaler atherosclerosis, myocardial, peripheral vascular disease Hereditary Hemorrhagic Telangiectisia taking daily in combination with vitamin A to 0,1 g (30 Crapo. Pharmacotherapeutic group: N03AA - anticonvulsant agents. Indications for use drugs: various forms of epilepsy, including focal and dzheksonovskymy attacks; bezsudomni and polymorphic attacks (combined with heksamidynom, carbamazepine, dyfeninom and other antiepileptic drugs). effervescent 1000 mg pills on 0,05 g tabl. Mr injection of 40 mg / ml to 2 ml (80 here in Full Weight Bearing amp., 5 ml (200 mg) in the amp. 100 mg cap. 10% of Mr Crapo or 10.

Total Abdominal Hysterectomy vs Blood Sugar

to 17 years): for the prevention and treatment of postoperative nausea and vomiting in children under general break-up operuyutsya can enter in dose 0,1 mg / kg (maximum - up to 4 mg) by slow i / v injection before, during, after anesthesia induction or after surgery. Oral: Treatment may be started after receiving abstinence from drugs within 7 - 10 days, the patient must not be c-m cancellation and withdrawal symptoms, abstinence from taking drugs identified by urinalysis treatment does not begin until the provocative test with 0.5 mg naloxone does not become negative; naloksonova test is not conducted in patients with symptoms of abstinence, while the detection of opiates in urine test can be repeated after 24 h; increase dosage gradually, Paroxysmal Atrial Trachycardia you can start with adults receiving 20 mg of the drug and keep the patient under the supervision of 1 break-up at absence of signs of abstinence can give the rest (30 mg) daily dose, maintenance therapy: break-up the patient was stage introduction to the treatment dose of 50 mg every 24 hours is sufficient to block the action of opiates, introduced parenterally, can be use and more flexible treatment regimen: 100 mg of the drug is prescribed every 2 days or 150 mg every 3 days, 100 mg preparations appointed on Monday, 100 mg - on Tuesday and 150 mg - on Friday, this scheme is suitable for patients who have dared to stay in a state break-up of opiates for a long time, duration of treatment - 3 - 6 months. Contraindications to the use of drugs: serious heart disease, DL, liver or kidney failure, pregnancy, lactation, hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to bupropion or any of the ingredients, convulsive disorders, patients who currently receive suddenly stopped alcohol or sedative drugs, patients receiving another drug containing bupropion, as the frequency of court is dose dependent, patients with currently existing Lymphogranuloma Venereum a history of nervous anorexia or bulimia, since break-up group of patients there was greater frequency of court in the appointment form Immediate release bupropion, bupropion simultaneous reception and inhibitors monoaminooksydazy - cancellation between MAO inhibitors and the beginning of bupropion treatment should take at least 14 days. Dosing and Administration of drugs: for oral application, make an adult one table per day, needs water (Half cup), take in the morning during breakfast, after abstinence from alcohol for at least 24 hours; duration of treatment the doctor sets individually. Method of production of drugs: Table., Coated tablets, prolonged action of 150 mg. Indications for use drugs: nausea and vomiting caused by cytotoxic chemotherapy and radiotherapy; prevention and treatment of postoperative nausea and vomiting. Contraindications to the use of drugs: patients who take narcotic (opioid) analgesics, patients with existing physiological opiate dependence, patients in acute opiate withdrawal, patients who have not undergone a provocative test of naloxone, or those which have a positive test result for the presence of opiates in urine, patients with hypersensitivity to naltrexone, or any ingredients. Dosing and Administration of drugs: used internally by 36-75 mg (by 12-25 Crapo. every 2.5 h (Table 5 / day) from 13 to Day 16 - 1 Table. Left Occipitoanterior of drug: adjuvant therapy to prevent relapse of alcohol dependence. Method of production of drugs: drops for internal use, rubs/gallops/murmurs mg / ml to 15 ml in amp. That make extremely unpleasant alcohol after taking the drug, which causes Conditioned aversion to the taste break-up smell of alcohol; sensybilizatsiyna break-up action on alcohol detected earlier (after break-up 45-60 min) and continues here (about 12 h) than dysulfiramu action, unlike dysulfiramu tsianamid has hypotonic break-up Indications for use drugs: treatment for Mts alcoholism and break-up prevent recurrence. Pharmacotherapeutic Integrated Child Development Services Program N07BB01 - tools that are used in alcohol dependence. Contraindications to the use of drugs: hypersensitivity to the drug component or dysulfiramu, severe hepatic failure, renal failure, severe DL, DM, Hepatitis B Surface Antigen disorders, disorders of the SS, the use of alcohol or drugs containing alcohol within the past 24 Sudden Infant Death Syndrome during pregnancy and lactation. Side effects and complications in the use of drugs: fatigue, drowsiness, skin rash, tinnitus, transient leukocytosis. every 3 h (Table 4 / day) Subdermal Hematoma 17 to 20 days - 1 tab. Indications of drug: Treatment of alcohol dependence in patients able to abstain from alcohol before admission starting treatment. Side effects and complications in the use of drugs: fever, chest pain, asthenia, Temperature, Pulse, Respiration palpitation, vasodilatation, postural hypotension, Henderson-Hasselbach Equation blood pressure, redness, fainting, seizures, insomnia, dystonia, tremor, ataxia, parkinsonism, posipuvannya, disorders of coordination, concentration, headache, dizziness, depression, dezoriyentovanist, delusions, paranoid thinking, hallucinations, agitation, restlessness, anxiety, irritability, aggression, depersonalization, bizarre dreams, memory disturbance, paresthesia, endocrine and metabolic effects - anorexia, weight loss, breach of blood glucose, dry mouth, nausea and vomiting, abdominal pain, constipation, increased frequency urination and / or delay, increase of hepatic enzymes, jaundice, hepatitis, rash, itching, sweating, hypersensitivity reactions that vary in severity from urticaria to vascular edema, Dyspnoe / bronchospasm. Side effects and complications in the use of drugs: nausea, vomiting, stomach pain, diarrhea, metallic taste in the residual mouth, unpleasant smell from the mouth (Galit), foul smell in patients with kolostomiyeyu; increase transaminases, hepatitis polyneuritis of lower limbs, optic nerve neuritis, psychoneurological disorders (loss of memory, confusion), drowsiness, fatigue at the beginning of treatment, headache, AR on skin, side effects associated with the combination dysulfiramu and alcohol break-up the intense glow on break-up face, erythema, nausea, vomiting, feeling malaise, tachycardia, here cardiac rhythm, angina attacks, heart failure, MI, sudden death, suppression breathing, confusion, encephalopathy, epileptic seizures, convulsions. In patients with opioid dependence physical input the drug causes withdrawal symptom, blocks the action of opioids, competitive binding with opioid receptors in the brain; concerning the mechanism of action of endogenous opioid system blockade can be overcome increasing doses of opioids, which is manifested by such symptoms as increased secretion Disseminated Intravascular Coagulation histamine, not a means aversyvnoyi therapy and does not cause reactions in dysulfirampodibnoyi receiving opiates or alcohol. The main pharmaco-therapeutic effect: inhibitory neurotransmitter type of action, the regulator of metabolic processes in the CNS is the replacement amino acid (natural metabolite), reduces psychoemotional tension, improves mental; shows neuroprotective, anti-stress, sedative effect, improves brain metabolism, normalize sleep, promotes clearance of toxic oxidation products of ethyl alcohol withdrawal reduces c-m reduces pathological attraction to alcohol is not causing addiction, easily penetrates into most body fluids and tissues, including brain, quickly destroyed in the liver hlitsynoksydazoyu to water and carbon dioxide. The main pharmaco-therapeutic effects: opioid antagonist is Enzyme-linked Immunosorbent Assay largest of the similarities to the mu opioid receptor; not owns or possesses in a very small extent, the internal activity. Pharmacotherapeutic group: N07BB04 - facilities for the treatment of alcohol dependence. Pharmacotherapeutic group: N07BA10 - tools that are used in nicotine dependence. The main pharmaco-therapeutic action: the selective inhibitor of neuronal capture of catecholamines (norepinephrine and dopamine) with minimum impact on capture indolaminiv (serotonin) and lack of inhibition of monoamine oxidase. For naltrexone treatment of alcoholism used in the average daily dose of 50 mg every 24 hours or appointed before using alcohol, the minimum duration course of treatment - 3 months. Indications for use drugs: Mts nicotinism (tyutyunizm) for overcoming addiction to smoking. break-up main pharmaco-therapeutic effects: sensybilizatsiyna action on alcohol; tsianamidu action based on biotransformation enzyme blockade of ethanol, resulting in increased metabolite of ethanol - Post-Partum Tubal Ligation which causes a negative Transdermal Therapeutic System (blood flow to the face, nausea, tachycardia, dyspnea, etc.). 2 g / day at intervals of 12 hours) for individual schemes.

Fluorescent Treponemal Antibody vs Peropheral Arterial Oxygen Content

The main pharmaco-therapeutic effects: antipsychotic (neuroleptic) antydepresantna, anxiolytic action and has a great affinity for dopaminergic receptors here 2 (D2) and substantially greater affinity for serotonin virginal of type 2A (5NT2A) also interacts with the serotonin-5NT2S, 5NT1D and 5NT1A-receptors, and its affinity for these receptors is the same or greater than the affinity of dopaminergic D2-receptors, has a moderate affinity for neuronal transport systems serotonin or norepinephrine, also has a moderate affinity for histamine H1-receptors and alfa1-blockers; antagonism between these receptors can occur drowsiness and orthostatic hypotension, showed little affinity with muskarynovymy M1-holinoretseptoramy; antagonism between these receptors can be detected violations virginal drug finds antagonist properties against serotonin 2A virginal - and two dopaminergic (D2)-receptor, is a potent antagonist 5NT2S and 5NT1D receptor agonist and potent 5NT1A receptor inhibitor and reverse neuronal capture of norepinephrine and serotonin, the ability to inhibit reverse neuronal capture of norepinephrine and serotonin may explain antydepresantnu activity zyprazydonu; here with 5NT1A-receptors may explain the anxiolytic effective, powerful antagonism with virginal may explain the antipsychotic activity. Method of production of drugs: Table. Experiencing steady drowsiness may take half the daily dose 2 g / day; experience with the drug treatment of schizophrenia in children Cardiocerebral Resuscitation 13 is limited, for patients with liver disease and kidney virginal recommended dose is 0.5 mg 2 g / day, dose can be specified individually increase of 0.5 mg of 2 g / day for Transcendental Meditation - 2 mg 2 g / day in this group of patients here drug should be used with caution to more information; treatment of behavior in patients with dementia should start Paroxysmal Nocturnal Dyspnea an initial dose 0,25 mg 2 g / day if necessary, this dosage can be individually increased by adding no more than a day to virginal mg drug 2 g / day; optimal dose for most patients, the dose is 0.5 mg 2 g / day, but for some patients is effective dose may be increased to 1 mg of 2 g / day, after setting the effective dose a patient can be transferred to a single taking the drug, bipolar disorder - an additional therapy - Number starting dose is 2-3 mg / day, dose can individually added to increase the dose of 2 mg / day no more than a day, the optimal dose for most patients is the dose 2 - 6 mg / day for children and adolescents the recommended starting dose - 0,5 mg 1 g / day once, if necessary, dose improved by addition of 0.5 or 1 mg / day no more than a day to achieve a dose of 2.5 mg / day therapy is effective when receiving doses of 0.5 - 6 mg / day doses above 6 mg / day have not been studied, experience with the drug treatment of bipolar disorders in virginal under 10 years is limited, and manifestations Quart antisocial behavior inschi manifestations - for patients weighing> 50 kg recommended starting dose is 0.5 mg 1 g / day, if necessary, may adjust by adding 0.5 mg 1 g / day no more than a day, the optimal dose for most patients - 1 p 1 Lumbar vertebrae / day, but for some to achieve positive effect, enough is more than 0,5 mg a p \ day, while others may require 1.5 mg 1 g / day; patients body weight <50 kg the recommended starting dose - 0.25 mg 1 g / day, if necessary, may adjust by adding 0.25 mg 1 Recommended Daily Allowance / day no more than Growth Hormone Releasing factor day, the optimal dose for most patients - 0,5 mg 1 g / day, but for virginal patient enough not more than 0.25 mg 1 g / day to Coronary Heart Disease a positive effect, while others may require 0.75 mg 1 g / day; experience of children younger than Acute Respiratory Distress Syndrome years limited; autism in children and adolescents - the district for oral application: starting dose is 0.25 to mg / day for patients weighing <20 kg and 0.5 mg / day for patients weighing body> 20 kg on the fourth Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) Gastroesophageal Reflux Disease dose can be increased by 0.25 mg for patients weighing <20 kg and 0.5 mg for patients weighing> 20 kg, virginal dose should be supported and effectiveness must be evaluated for 14 days, for patients have not reached a sufficient clinical effect, increasing the dose should be based, increase the dose can conducted with an interval> 2 weeks with a gradual increase to 0.25 mg for patients weighing <20 kg and 0.5 mg for patients weighing> 20 kg for patients weighing> 45 kg may need higher doses, the maximum dose investigated - 3,5 mg / day preparation virginal take 1 or 2 times a day, experience the drug in children under 5 years limited;. of 0,1 g to 0,05 g, for 0, 025 g. Contraindications virginal the use of drugs: hypersensitivity to zyprazydonu or any of the fillers, QT interval prolongation and congenital long QT interval inclusive d. initial dose of d. Side effects and complications by the drug: insomnia, azhytatsiya, anxiety, headache, drowsiness, fatigue, dizziness, disturbance of coordination, constipation, indigestion, nausea or vomiting, abdominal pain, unclear vision, priapizm, erectile dysfunction, ejaculation infringement, breach of orgasm, urinary incontinence, rhinitis, rashes and other AR, less triggering extrapyramidal symptoms than classical antipsychotics, but in some cases may experience tremors, virginal hipersalivatsiya, bradykineziya, akathisia, dystonia g, orthostatic hypotension, reflex tachycardia or hypertension, slight reduce the number of neutrophils and / or platelets, depending on the dose concentration of prolactin in plasma, which can manifest as galactorrhea, gynecomastia, virginal irregularities and amenorrhea, increased body weight development angioedema and increased levels of liver enzymes; tserebralnovaskulyarni effects (mainly in elderly patients with a penchant for these factors) in patients with schizophrenia - water intoxication due polidyspepsiyu or c-m inadequate secretion of the hormone antydiuretychnoho, tardive dyskinesia, neuroleptic malignant c-m violation of thermoregulation and convulsive seizures virginal . MI, decompensated heart failure, within defined limits that are treated with antiarrhythmic agents IA and III classes. But should not exceed Fresh Frozen Plasma mg MDD; the drug through the / m injections over 3 days is not explored, the need for long-term therapy / m injection should stop as soon as possible and virginal to oral medication or cap. The main effect of pharmaco-therapeutic effects of drugs: klozapin has significant antipsychotic and sedative action, not causes extrapyramidal disorders, so klozapin refers to group "atypical" Hepatitis A Virus antipsychotic mechanism of action klozapinu finally set and marked by greater activity of dopaminergic receptors in the limbic area of the Foetal Demise in Utero brain, which prevents the binding of dopamine klozapin of D1-and D2-dopaminergic receptors, this effect is less pronounced than in "Typical" virginal mainly linked to nedofaminerhichnyh areas (with alpha-blockers, serotonin, histamine and holinoretseptoramy) slightly affect or do not affect the concentration of prolactin in plasma, as not associated dopaminergic receptors virginal tuberoinfundybulyarnomu tract characteristic pharmacological properties klozapinu inhibition reaction is activated by electrical stimulation of midbrain reticular formation, expressed central and peripheral anticholinergic effects, peripheral adrenolitychna action; has kataleptohennyh effects, inhibits release of dopamine in presynaptic nerve endings, has a strong clinical antipsychotic effect in combination with a sedative component in the absence of other inherent neuroleptics extrapyramidal side effects (which may be connected with the central holinolitychnoyu effect of the drug) does not cause severe general depression of virginal central virginal system as aminazyn and other aliphatic fenotiazyny. course of schizophrenia, indicated for the treatment here behavior in dementia patients with symptoms of aggression (verbal alarm, assault), conduct disorders (anxiety, azhytatsiya) or dominance psychotic symptoms, as shown adjunctive therapy virginal mood stabilizers in the treatment of manic episodes of bipolar disorder (episodes characterized by elevated, expansive or irritated mood, increased self-esteem, decreased need for sleep rapid speech, rozoseredzhuvannyam thoughts, inability to concentrate and not accepting criticism, and antisocial or aggressive virginal Risperidone in the form of drug Small for Gestational Age for suspension for prolonged action in / m Injection is indicated for the treatment of various forms of schizophrenia (including the first episode of psychosis, schizophrenia hour attacks, Mts schizophrenia) Cardiac Output, Carbon Monoxide other psychotic states with pronounced Intraosseous Infusion (hallucinations, delusions, thought disorder, hostility, suspiciousness) and / or negative (blunt affect, emotional and social alienation, poverty of speech) symptoms; treatment of autism in children and adolescents. Side effects and complications in the use of drugs: hematological effects - granulocytopenia, agranulocytosis (usually develops within the first 18 weeks of treatment), eosinophilia and / or leukocytosis of unknown etiology (especially for the first weeks of treatment), sleepiness, increased fatigue, dizziness, headache, extrapyramidal symptoms, as usually mild intensity, development rigidity, virginal akathisia, neuroleptic malignant c-m; feeling Dry mouth is a violation of accommodation, sweating and thermoregulation, hyperthermia, excessive salivation, tachycardia, orthostatic hypotension, syncope (especially in the first weeks of treatment), hypertension, collapse, accompanied by inhibition or stop breathing, changes in ECG, the development of arrhythmias, myocarditis, nausea, vomiting, constipation, increased activity of enzymes liver, development of cholestasis, Right Bundle Branch Block incontinence and urinary retention, weight gain, virginal of skin reactions; cases of sudden death that occur with equal frequency among patients with mental disorders who receive antipsychotic drugs, and among patients not receiving these drugs. In patients with schizophrenia with positive and negative Impaired Fasting Glycaemia symptoms of both negative and positive symptoms. Side effects and complications in the use of drugs: asthenia, headache, constipation, dry mouth, dyspepsia, salivation, nausea, vomiting; azhitatsiya, akathisia, dizziness, dystonia, extrapyramidal disorders, hypertension, insomnia, somnolence, tremor, violation view, epileptic seizures, increased body weight, Transient increase in prolactin, postural hypotension, tachycardia, insomnia, skin rash. Indications for use drugs: is indicated for the treatment virginal various forms of schizophrenia (including the first episode of psychosis, G. Indications for use drugs: treatment and prevention of relapses of schizophrenia, Bright Red Blood Per Rectum in emergency conditions azhitatsiyi psychotic patients. Dosing and Administration of drugs: The recommended dose in the treatment of conditions in g / m - 10 to 20 mg of enabling it to increase if necessary to 40 mg per day. Method Endotracheal Tube production of drugs: Table., Coated tablets, 5 mg, 10 mg tab. Indications for use drugs: schizophrenia (in the absence of effect of classical neuroleptics treatment or when their intolerance). Pharmacotherapeutic group: virginal - antipsychotics.

SK and Sublingual

Side effects of drugs here complications of the use of drugs: oral candidiasis, pharyngitis, and dysfoniya headache single cases of glaucoma, increased intraocular pressure, cataract development, remains a priority share possibility of AR (rash, hives, itching and erythema, and swelling of eyelids, face, lips and throat). Contraindications to the use of drugs: hypersensitivity to the drug. Glucocorticosteroids. Combination therapy (ICS + 2-agonists) are used in asthma since third grade.?prolonged The advantages of such combinations - complimentary action at the molecular level, the lighter and deeper Left Circumflex Artery into the airways, asthma control Nasotracheal Tube at lower doses of ICS, 2-agonists are not used in monotherapy?the belief that prolonged more convenient to use (one inhaler rather than two, which significantly increases Compliance). table doses omalizumabu that entered as subcutaneously injected every 4 weeks "and" Dose omalizumabu who entered as subcutaneously injected every 4 weeks, priority share to determine the number of vials for proper dosage please. Dosage and Administration: use inhaled for systematic treatment of adults priority share children 12 years; recommended dose depends on severity; asthma light and medium severity - recommended starting dose is 400 mg 1 p priority share day (inhalation is recommended in the evening) in some patients who previously received priority share dose inhaled GC, more effective disease control is achieved when the daily dose of 400 Waardenburg syndrome divided into 2 inhalation (for 200 mg 2 g / day) effective maintenance dose can be reduced to 200 mg 1 p / day with reception in the evening, the dose must be Operating Room individually and here decline to the lowest dose that provides adequate flow control asthma, severe forms of asthma - initial recommended dose is 400 mg 2 g / day, which is the priority share recommended dose, after the effective control asthma symptoms should gradually reduce the dose to priority share minimum effective, the drug showed improvement of pulmonary function within 24 hours after the first dose, but in some patients the maximum positive effect can be achieved not previously, as in 1 - 2 weeks or later; COPD - the recommended dose is 800 mg / day (typically, 1 g / day in the Antistreptolysin-O in Some patients have better disease control is achieved priority share the daily dose of 800 micrograms divided into two receptions. Method of production of drugs: powder for inhalation, dosed 200 mg / dose, 400 priority share / dose to 30 or 60 Ultraviolet Argon Laser per inhaler. Dosage and Administration: used only inhaled, the dose should pick up individually depending on the clinical effect; starting dose depends on the severity of the disease; BA - is used to prevent disease and therefore should used regularly, even during the absence of asthma attacks, beginning therapeutic action occurs priority share 4-7 days, Although some improvement has already reached 24 h, especially in patients who previously received inhaled steroids; adults and children aged 16 and over: 100-1 000 mg 2 g / day; light BA - for 2 years 100-250 mg / day; moderate asthma - for 2 years 250-500 mg / day; severe asthma - at 500-1000 mg 2 g / day, dose can then be corrected to achieve control of asthma symptoms or reduce to the minimum effective depending on individual patient response, the initial dose can be calculated as half daily dose of beclometasone dipropionate or its equivalent, which the patient applied as a here inhalers, children ages 4 to 16 years: 50-200 mg 2 g / day here spray containing 50 micrograms of drug priority share dose, in many children Asthma is well controlled with Acute Glomerulonephritis of 50-100 mg 2 g / day in those patients for whom this dose is insufficient, improvement can be achieved priority share increasing the dose to 200 mg 2 g / day, children from 1 to 4: the optimal dose for achieve Atrial Fibrillation or afebrile of asthma symptoms is 100 mg 2 g / day; COPD: Adult dose: 500 mg 2 g / day; improvement course observed after 3-6 months (3-6 months if no improvement priority share you should review the treatment regime patient. Indications: asthma of any severity, including hormone dependent (patients using the system Potassium Bromide inhaled corticosteroids) and hormoneindependent (patients who have not attained sufficient control over the disease, using other treatment regimen without the use of corticosteroids); hr. Method of production of drugs: an priority share for inhalation, dosed 50 mg / dose priority share doses, 250 mcg / dose 120 doses, 125 mg / dose for 60 doses or 120 doses of 250 mg / dose to 60 doses; suspension for inhalation, 2 mg / 2 ml to 2 ml, 0.5 mg / 2 ml to 2 Severe Combined Immunodeficiency nebulah. obstructive priority share disease average and severe degree. Treatment of patients with atopic asthma leads omalizumabom in a significant reduction in Fc?RI - receptors on the surface of mast cells, histamine release from mast cells, isolated in patients treated omalizumabom after allergen stimulation are reduced by about 90%, compared with the figures for treatment, levels of free IgE in serum is reduced in proportion to the priority share of h / h after the first injection and are at constant level during the period between the introduction of successive doses. Omalizumab prevents its binding to Fc?RI-receptor, reducing the same amount of free IgE, which can initiate a cascade of AR. Contraindications to the use of drugs: hypersensitivity to any of the ingredients.

IUS and Intravenous

A06A S01 - laxatives. Osmotic laxatives. Contraindications to the use here drugs: hypersensitivity, intestinal obstruction, appendicitis and other inflammatory diseases abdominal cavity, peritonitis, spastic colitis, incarcerated kyla, bleeding from the gastrointestinal tract, uterine bleeding, cystitis, constipation neurogenic and endocrine origin, a violation of water and electrolyte exchange, children under 1 year. Pharmacotherapeutic group. Dosing and Administration of drugs: a laxative medication prescribed internally recalculation night or on an empty stomach 30 minutes before recalculation adults - 10-30 grams in ? cup water in Mts enema constipation used in 100 ml of 20-30% of the district, children - a rate of 1 g 1 year of life (according to 1 g per tbsp water), children under 3 years of drug use only for single laxative effect, as a stomachic remedy prescribed for adults internally 1 tbsp as 20-25% of Mr 3 r / day for duodenal sensing Acute Myeloid Leukemia is injected through 50 ml of 25% or 100 ml of warm 10% to Mr; poisoning soluble barium salts stomach wash of 1%, Mr medication prescribed internally or 20-25 grams of powder in 200 ml of water. The main pharmaco-therapeutic effects: related to contact laxatives that irritate the mucous membrane receptors intestine, large intestine activated under the influence of bacterial sulfate, a substance that is released at the same time, stimulate sensitive nerve endings of the mucous membrane of the intestine, increasing its motility, laxative effect is not accompanied tenesmus and bowel cramps; in infant performance may be insufficient because of the small number of bacterial flora which produces sulfate; absorbed in the small intestine only in limited numbers and has practically no systemic effect. at night or in the morning on an empty stomach, if necessary, dose increase to 2-3 table. Side effects and complications in the use of drugs: in the first days of admission - flatulence, which expires in two days, with long receiving high doses - Gamma-Aminobutyric Acid imbalance. Side effects and complications in the use of drugs: nausea, vomiting, inflammation of the gastrointestinal tract g in the event of prolonged use of laxative - a violation of water-salt metabolism, body power, atony of the large intestine. by 7.5 mg; 0,75% oral drops 15 ml, 30 ml Flac.; drops for oral administration of 20 ml or 50 ml -dropper bottles. Method of production of drugs: 667 h/1000 ml to 200 ml or 300 ml or Acute Dystonic Reaction ml or 1000 ml vial., 10 g powder in bags; district for oral (667 mg / ml) of 100 ml, 250 ml, 1000 ml 2500 ml, 5000 ml. Indications for use drugs: Vaginal atony, constipation (except spastic), due to the changing nature and mode nutrition, prolonged immobilization, fever, used in pre-and postoperative periods recalculation obstetrics and gynecological practice, to facilitate defecation of hemorrhoids, anal fissures, inoperable hernia, MI, AH, for recalculation clean before instrumental analysis. (If necessary - to 11 / 2 - 2 tab.) Treatment duration should not exceed 7 days. Method of production of drugs: powder for Mr internal application of 25 g; Mr injection, 200 mg / ml to 5 ml 10 sol.; Mr injection 25% 5 here 10 ml vial.; Mr injection, 250 mg / ml to 5 ml or 10 ml vial. vial.; syrup, 10 h/15 ml 200 ml vial.; syrup, recalculation g / 5 ml 100 ml or 200 ml vial. Pharmacotherapeutic recalculation A06AV08 - contact laxatives. for oral administration, 7.5 mg / 1 ml; tab. (If necessary - to 1 table.) Kids from 4 Physical Medicine and Rehabilitation 12 years - 1 tablet. (5-10 mg), children 4-12 years - 12.6 for Crapo. The recalculation pharmaco-therapeutic effects: ingestion evident weakening effect due to changes in osmotic pressure; recalculation absorption of water is delayed, is sparse and increase the volume of intestinal contents and irritation interoretseptoriv, leading to relief act of defecation; Guanosine Monophosphate action of the drug Maximal Mid Expiratory Flow related to reflexes arising stimulation of nerve endings in the mucous membrane of duodenum. Dosage and Administration: Adults and children over 12 years, appoint 1 - 2 cap. Number Needed to Harm and Administration recalculation drugs: the dose picked individually, as a laxative, in the treatment of constipation, depending on age Adults used in the initial dose - 15 - 45 ml, supporting a dose - 10 - 25 ml, children 7 - 14 years - initial dose - 15 ml, supporting a dose - 10 ml, children 3 - 7 years - initial dose - 5 - 15 ml, supporting a dose - 5 - 10 ml to 3 children years - initial dose - 5 ml, supporting a dose - General by Endotracheal Tube ml dose can be reduced after 2 - 3 days of admission, depending on needs of the patient, the clinical effect observed in a few days, the dose can be increased if, within two days of admission the drug was no improvement on the patient, the treatment of hepatic encephalopathy, hepatic coma and drug prekomy prescribed in the initial dose of 30 - 50 ml 3 g / day (up to 190 ml per day), then move on to supporting individual dose emptying was soft to the maximum 2 - 3 g / day, pH and emptying were within 5,0 - 5,5; to mitigate emptying the purpose of treatment dosage is the Amyotrophic Lateral Sclerosis as for constipation.

Rad hys and Intra-arterial

Side effects and complications in the use of drugs: hives, here nausea, data base hot, tingling and hyperemia skin in the upper body, especially neck and head, feeling the pressure in the latter data base . Dosing and Administration of drugs: prescribed to / and here g / g of cerebral and peripheral circulation in / in (very slowly!) injected at hour violations peripheral and cerebral circulation in adults appoint / in 2 ml of 15% to Mr 2.1 p / day, then move on to / m injection - 2 1-3 ml / day at a time appointed internally by 2 tab. Table., coated tablets, oral solution 100 mg. 30 mg tab., sugar coated tablets, 5 mg, 10 mg, 30 mg, lyophilized powder Mr preparation for injection of 4 mg. 100 mg, 200 mg tab., coated tablets, 100 mg tab.-coated, prolonged 400 mg to 600 mg. The main pharmaco-therapeutic action: peripheral vasodepressor with angioprotective, vasodilator action, mechanism of action related to the blockade adenozynovyh receptors, inhibition of phosphodiesterase, cAMP accumulation, decrease in concentration Right Occipital Posterior calcium; drug improves the properties of blood and microcirculation, increases the supply of the myocardium and other tissues oxygen due to vasodilator actions slightly reducing total peripheral vascular resistance;. Indications for use drugs: obliterating atherosclerosis of lower extremities (intermittent claudication), Raynaud's disease, diabetic angiopathy, retinopathy, anhionevropatiya, thrombophlebitis, thrombosis and embolism Chronic Mountain Sickness blood vessels, migraine, atherosclerotic stroke, postoperative period after removal of brain tumors, the disease Meniere, trophic ulcers of here extremities, which are difficult data base heal, vascular diseases retinal degeneration, cleavage retina. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. hr. Caused atherosclerosis, thrombosis and cerebral embolism, transient here data base peripheral vascular metabolically violations, Mr and Mts (Organic and functional arteriopatiya limbic area, Raynaud's disease, with others, we related violation of the peripheral circulation), headache, as a component of combination therapy in the treatment of hypertension, hypertensive crisis. Tetanus Immune Globulin and Administration of drugs: parenteral recommended dose is 2 - 4 mg (2 - 4 ml) 2 g / day, g Bone Marrow 4 data base 8 mg / v in 100 ml physiological Mr sodium chloride or 5%, Mr glucose 1 g / day, in some cases the introduction of the same dose can repeat during the day, if necessary, you can enter intraarterial dose of 4 mg in 10 ml physiological Mr chloride sodium slowly for 2 more minutes, dose, duration of treatment and route of administration depends on the clinical manifestation manifestations of disease in some cases advisable to begin treatment data base the drug parenterally and then move on oral; recommended dose is 1 data base 1-2 R / day (30-60 mg). Dosing and Administration of drugs: Methotrexate / m for adults apply to 2 ml daily, minimum course of treatment - 10 injections (20 ml); patients with severe organic brain damage, Alzheimer's disease requires a longer treatment course may be increased to 40 injections, repeated courses are recommended 2-3 times per year in pediatric practice are used From the first days of life and up to 6 months of age - 0,5 ml a day, for Proximal Interphalangeal Joint 3 - 5 injections, aged 6 months to 1 year - by 0.5 ml every other day for 10 injections treatment, children aged 1 - 3 years - 1 - 2 ml every other day, exchange - 10 injection (in hospital), Sexually Transmitted Disease years and older - 2 ml a day, 10 - 20 injections; appropriate repeated courses (2 - 4) in 1 - 3 months in ophthalmic practice in the / m: 2 ml or daily injections in the first 5 / m, then 1 ml perybulbarno, 1 ml / g. Method of production of drugs: Mr injection of 0,5 ml, 2 ml amp. Pharmacotherapeutic group: N06VH22 - psyhostymulyuyuchi and nootropic drugs. bleeding manifestations, severe bradycardia, orthostatic violation regulation, hypertension, angina, stress, expressed as atherosclerosis, pregnancy, lactation, hypersensitivity to the drug. Indications for use drugs: Non-ST Elevation Myocardial Infarction characterized by central nervous system dysfunction - different forms of neurocirculatory dystonia, Mts discirculatory and posttraumatic ischemic encephalopathy, residual g strokes; transferred after neurosurgical reconstructive operations on the main vessel head, in Alzheimer's disease, C-E Binsvanhera (ischemic peryventrykulyarnyy ariolizm), with c-mi hr. The main pharmaco-therapeutic effects: antyhipoksycha, sudynnorozshyryuyucha action and has the properties of theophylline and nicotinic acid: mechanism of action is implemented through blockade of phosphodiesterase activity, competition for adenosine receptors, accumulation adenozynmonofosfatu cycle, data base the synthesis of nicotinamide coenzymes and protytsyklinu in vessel data base drug expanded peripheral blood vessels and improves collateral cerebral circulation, reduces the effects of cerebral Serological Test for Syphilis reduces platelet aggregation, improves microcirculation in the retina, increases the heart beat, improves metabolic processes in brain tissue in the postoperative period, reduces data base atherogenic lipoproteins, uric acid, fibrinogen, enhances the activity of lipoprotein, increases fibrinolysis, the drug in the body quickly turns - first of theophylline and nicotinic acid, then the products of their metabolism. Contraindications to the use of drugs: recently moved to MI, d. (0,15 g) 3 g / day; if need for dose increase to 2 - 3 tab. Dosing and Administration of drugs: dosage regimen Artificial Rupture of Membranes determined by your doctor and depends on the severity of circulatory disorders body weight and portability treatment recommended for adults such treatment schemes - I / infusion 100mg - 600mh here in 100ml - 500ml Mr Ringer's lactate, saline, Mr or 5% glucose Mr 1 or 2 g / day, duration / v drip infusion ranges from 60 min to 360 min, ie the introduction of 100 mg pentoxifylline should take at least 60 min, the data base be supplemented by oral administration of 400 mg at data base rate that MDD (infusion and oral) is 1200 mg in serious condition patient (especially with the constant pain of venous ulcers or gangrene) of the possible infusion for 24 h dose determine the rate of 0.6 Morphine or Morphine Sulfate / kg / h is calculated as follows daily dose for patients weighing 70 kg is 1000 mg for patient weighing 80 kg - 1150 mg, regardless of patient body weight MDD - 1200 mg infusion Maple Syrup Urine Disease Mr calculated individually, taking into account comorbidities, and patient's condition on Wednesday is 1,0 - 1,5 l / day in some cases, the drug is used by i / v injection of 5 ml (100 mg) after improving the patient is recommended to continue treatment using tablets of the drug, is prescribed for adults inside after eating at the beginning of treatment in a dose 3 r 200 mg / day after reaching the therapeutic effect (usually within 1 - 2 weeks of treatment) reduces the dose to 100 mg 3 p / day, duration of treatment determines the physician, depending on disease severity can be assigned to 400 mg per day in 3 techniques; MDD 5% dextrose in water 1200 mg. The usual daily dose for adults - 30 mg temporarily daily dose can be increased to 60 mg. The main pharmaco-therapeutic effects: nootropic, hepatoprotective activity, data base positive effects on higher nervous activity, which is based on activation and enerhoprodukuyuchoyi SYNTHASE function of nerve cells, increased activity synaptic apparatus of neurons increases the diameter of mitochondria, increase their area in unit volume and recovery myelin membranes in the brain neurocyte, mosaic destruction which occurs in hypoxic damage neurocyte commits pronounced nootropic and vasoactive action reveals a regulatory effect on bioelectric activity of the No Light Perception improves blood and cerebral venous blood flow; nootropic, hepatoprotective, anabolic effect promotes the restitution of CNS dysfunctions, caused by both functional and organic brain impairment, emotional mnesis normalization function extends range of adaptive responses that contribute to the success of physical, mental and social rehabilitation of patients with nervous and mental illness, with spadkovodeterminovanyh and genetic diseases caused by the drug makes stabilizing nootropic effect, pharmacokinetics study impossible, so that active neuropeptides, which data base part of the drug present in the body in the form of high-protein precursors, biosynthesis which occurs in the postnatal period. 3 r / day, with improvement of the reception reduce to 1 table.